JEFFREY KIRSHNER, M.D.
Hematology & Oncology Physician · EAST SYRACUSE, NY
Individual Active NPI 1447230420
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 640 | 148,644 | $6,916,865 | $3,432,359 | $2,734,662 |
| 2023 | 734 | 237,381 | $10,520,375 | $4,738,477 | $3,776,478 |
| 2022 | 676 | 135,770 | $5,742,747 | $2,558,600 | $2,039,162 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | 15,750 | $1 | $1 |
| J9299 | Injection, nivolumab, 1 mg | 11,616 | $31 | $25 |
| J0185 | Injection, aprepitant, 1 mg | 11,180 | $2 | $1 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 10,980 | $49 | $39 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 10,430 | $3 | $2 |
| J9271 | Injection, pembrolizumab, 1 mg | 9,600 | $56 | $45 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 6,980 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 3,540 | $25 | $20 |
| J1930 | Injection, lanreotide, 1 mg | 3,240 | $48 | $38 |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 2,970 | $48 | $39 |
| J9041 | Injection, bortezomib, 0.1 mg | 2,511 | $2 | $1 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,948 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 130489-1 | NY |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in New York
- NPI 1538197975
- NPI 1487945564
- NPI 1710204573
- NPI 1962497529
- NPI 1568676831
- NPI 1144209503
- NPI 1477846236
- NPI 1588360523
See all Hematology & Oncology Physician providers in New York →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.